Case reports of breast cancer patients with BRCA1 or BRCA2 mutations having post-radiation sarcoma have been reported [10], but a more extensive cohort study of BRCA1 and BRCA2 mutation carriers treated for breast cancer found no increased risk for radiation in-field secondary sarcoma after breast radiotherapy [11]. This evidence concerns the gene BRCA1 and breast cancer.